Real‐world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk

Author:

Brook Rowena1ORCID,Aswapanyawongse Oranut1,Tacey Mark23,Kitipornchai Tanun2,Ho Prahlad14,Lim Hui Y.14ORCID

Affiliation:

1. Haematology Department Northern Health Melbourne Victoria Australia

2. The Northern Hospital Melbourne Victoria Australia

3. Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

4. Northern Pathology Victoria Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Reference28 articles.

1. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population

2. Pricewaterhouse Coopers for the National Stroke Foundation. The Economic Costs of Atrial Fibrillation in Australia.2010[cited 2019 May 26]. Available from URL:https://www.hps.com.au/wp-content/uploads/2016/10/Economic-costs-of-atrial-fibrillation-in-Australia.pdf

3. Pharmaceutical Benefit Scheme: Drug Utilisation Sub‐committee Australian Government Department of Health. Novel Oral Anticoagulants: Predicted vs actual analysis.2016[cited 2019 May 20]. Available from URL:http://www.pbs.gov.au/info/industry/listing/participants/public-release-docs/2016-06/noacs-non-valvular-atrial-fibrillation-june-2016

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3